KVUE | tickerfilter.com

Fundamental analysis

63%

Profitability 63%

Dept financing 41%

Liquidity 35%

Performance 74%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

1.18%

1 Month

-0.06%

3 Months

4.81%

6 Months

-18.47%

1 Year

-20.76%

2 Year

-19.16%

Key data

Stock price

$17.21

P/E Ratio

21.99

DAY RANGE

$17.00 - $17.24

EPS

$0.74

52 WEEK RANGE

$14.02 - $25.17

52 WEEK CHANGE

-$20.07

MARKET CAP

31.511 B

YIELD

5.01%

SHARES OUTSTANDING

1.916 B

DIVIDEND

$0.2075

EX-DIVIDEND DATE

11-12-2025

NEXT EARNINGS DATE

08-05-2025

BETA

-0.11

PUBLIC FLOAT

AVERAGE 10 VOLUME

$34,440,849

AVERAGE 30 VOLUME

$35,213,838

Company detail

CEO: Thibaut Mongon
Region: US
Website: www.jnj.com/kenvue/
Employees: 0
IPO year: 2023

Issue type: Common Stock
Market: NYSE
Industry: Consumer Goods/Perfumes, Cosmetics And Other Toilet Preparations
Sector: Manufacturing

We are the world’s largest pure-play consumer health company by revenue with $15.0 billion in net sales in 2022. We combine the power of science with meaningful human insights and digital-first capabilities, which we believe empowers approximately 1.2 billion people to live healthier lives every day. Prior to the completion of this offering, we are a wholly owned subsidiary of Johnson & Johnson. Our principal executive offices are located at 199 Grandview Road, Skillman, NJ.

KVUE - Kenvue Inc.